C.M. Bidwell & Associates’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-35
Closed -$3K 620
2021
Q4
$3K Buy
+35
New +$2.88K ﹤0.01% 506

Other funds holding ASTH

C.M. Bidwell & Associates's ASTH Position: Q1 2022 in Review

C.M. Bidwell & Associates sold out of Astrana Health (ASTH) in Q1 2022, closing a stake of 35 shares — an estimated $3K sold.

C.M. Bidwell & Associates first reported a position in ASTH in Q4 2021 and held it in 1 quarter. The position peaked at $3K in Q4 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.

  • C.M. Bidwell & Associates reported no remaining Astrana Health position as of Q1 2022 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 35 Astrana Health shares in Q1 2022, an estimated $3K.
  • C.M. Bidwell & Associates first reported a position in Astrana Health in Q4 2021 and held it in 1 quarter.
  • C.M. Bidwell & Associates's Astrana Health position peaked at $3K in Q4 2021.
  • 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2022, filed 29 Apr 2022.